Complement Factor P Activity Assay

Creative Biolabs offers customized complement Factor P (Properdin) activity assay services to help researchers, biotechnology companies, pharmaceutical developers, diagnostic teams, and translational laboratories characterize properdin function in purified systems, serum-based matrices, disease samples, animal models, and therapeutic screening programs.

Submit Your Request Now

Download our service brochure

Inquiry

Why Complement Factor P Activity Matters in Complement Research

Complement activation is highly regulated because the same cascade that protects the host from pathogens can also damage host tissues if amplification is not properly controlled. The alternative pathway is particularly important because it can continuously amplify complement activation once C3b is deposited on a surface. Properdin contributes to this process by stabilizing the alternative pathway C3 convertase, C3bBb, and supporting more persistent convertase activity on target surfaces.

A properdin activity assay can provide functional information that cannot be obtained by concentration measurement alone. For example, an ELISA may show that properdin is present in serum, plasma, or a biological fluid, but it does not necessarily prove that the protein is functionally active, correctly oligomerized, capable of binding relevant surfaces, able to stabilize convertase complexes, or responsive to candidate inhibitors. Similarly, genetic analysis may identify variants in the CFP gene, but functional testing is often needed to understand whether those variants alter complement activity.

Properdin activity testing is valuable for many research and development questions, including:

Whether serum or plasma has sufficient properdin-dependent alternative pathway activity.
Whether a mutation, deficiency, or disease state reduces properdin function.
Whether a therapeutic candidate blocks properdin-mediated complement amplification.
Whether recombinant or purified properdin retains biological activity.
Whether complement activation on cells, microbes, nanoparticles, biomaterials, or immune complexes is properdin-dependent.
Whether downstream complement readouts such as C3b/iC3b, C5a, Bb, C5b-9, or hemolysis are influenced by properdin availability or inhibition.
Whether in vitro findings can be translated into species-specific preclinical models.

Creative Biolabs designs properdin activity assays according to the biological question, sample type, desired pathway specificity, required sensitivity, and downstream decision-making needs of each project.

Great Minds Choose Creative Biolabs

Partner with Us

Our Complement Factor P Activity Assay Capabilities

Creative Biolabs provides multiple assay formats for assessing properdin activity. Depending on the project objective, assays can be configured as purified-protein systems, serum-based functional assays, cell-based complement activation models, surface deposition assays, hemolytic assays, inhibitor screening assays, or biomarker-linked readout panels.

Properdin-Dependent Alternative Pathway Activity Assay

This format is suitable for determining whether properdin is required for a specific complement activation event and whether reduced or enhanced properdin function changes the magnitude or duration of alternative pathway amplification.

Properdin Reconstitution Assay

Properdin-depleted serum can be reconstituted with purified or recombinant properdin to assess restoration of alternative pathway activity. This design is useful for confirming properdin dependency, comparing different properdin preparations, evaluating functional rescue, and assessing whether test articles interfere with properdin function.

C3 Convertase Stabilization Assay

Creative Biolabs can develop assays focused on convertase assembly, decay, and functional persistence. These assays may monitor C3bBb formation, convertase decay rate, Bb retention, C3 cleavage, or amplified C3b deposition over time. The assay can be customized to compare properdin-positive and properdin-deficient conditions, evaluate inhibitor effects, or determine whether a surface supports properdin-mediated convertase stabilization.

C3b Deposition Assay

Properdin activity can be reflected by enhanced deposition of C3 activation fragments on complement-activating surfaces. Creative Biolabs can quantify C3b, iC3b, C3d, or total C3 fragment deposition using ELISA-based, flow cytometry-based, imaging-based, or plate-based detection strategies.

Terminal Pathway Readout Assay

Because alternative pathway amplification can drive downstream complement activation, properdin activity may also be assessed by terminal pathway readouts such as C5b-9 deposition or soluble terminal complement complex formation. This format is especially useful when the project goal is to connect properdin function with cell lysis, inflammatory amplification, or terminal pathway activation.

Hemolytic Properdin Functional Assay

Hemolytic assays can be used to assess properdin-dependent complement-mediated lysis under alternative pathway conditions. Assay designs may use rabbit erythrocytes or other appropriate target cells depending on the study objective. Properdin depletion, reconstitution, pathway-specific conditions, and inhibitor controls can be included to support mechanistic interpretation.

Cell-Based Complement Factor P Activity Assay

For projects requiring a more physiologically relevant format, Creative Biolabs can design cell-based complement assays to evaluate properdin-mediated complement activation on live cells or fixed target cells. Possible targets may include endothelial cells, epithelial cells, tumor cells, blood cells, genetically modified cells, pathogen-like particles, or disease-relevant cell models.

Properdin Inhibitor Screening Assay

Creative Biolabs supports screening and characterization of therapeutic candidates targeting properdin or properdin-dependent amplification. Test articles may include monoclonal antibodies, bispecific antibodies, antibody fragments, peptides, aptamers, small molecules, engineered proteins, fusion proteins, recombinant regulators, or biological extracts.

Species-Specific Properdin Activity Testing

Preclinical complement studies often require careful species selection because complement proteins and therapeutic candidates may show species-specific activity. Creative Biolabs can support properdin activity testing in human, mouse, rat, cynomolgus monkey, non-human primate, and other species, depending on reagent availability and project requirements.

Discuss Your Needs

Key Readouts Available for Complement Factor P Activity Analysis

The best readout depends on whether the project is focused on upstream properdin function, convertase stabilization, pathway amplification, terminal pathway activation, therapeutic inhibition, or biological consequence. Creative Biolabs can develop single-readout or multi-readout panels to provide a comprehensive functional profile.

C3 Convertase-Related Readouts, C3 Fragment Deposition Readouts

Alternative/Terminal Pathway Biomarkers

Cell-Based Readouts

Drug Discovery Readouts

Workflow of Complement Factor P Activity Assay

Creative Biolabs provides a structured but flexible workflow for complement properdin activity assay projects. Each step can be adjusted according to the project stage, sample availability, regulatory expectations, and decision-making needs.

Complement Factor P activity assay workflow developed by Creative Biolabs. (Creative Biolabs Original) Fig. 1 Complement FP ELISA workflow (upper) and hemolytic assay of FP (lower).

Design Your Workflow

Assay Design Strategies

Properdin activity assays require careful assay design because properdin participates in a dynamic amplification system rather than functioning as a simple standalone enzyme. Creative Biolabs considers pathway specificity, assay surface, activation trigger, matrix composition, controls, kinetics, and endpoint selection when designing each project.

Pathway Specificity

To evaluate properdin activity, it is important to isolate alternative pathway activity from classical or lectin pathway effects. Assay conditions may include magnesium-EGTA buffers, pathway-selective activators, properdin-depleted serum, complement component-depleted matrices, and pathway-specific positive or negative controls.

Properdin Dependency

Properdin dependency can be demonstrated by comparing normal serum, properdin-depleted serum, and reconstituted serum. If activity is reduced in depleted serum and restored after properdin reconstitution, the assay provides stronger evidence that the measured signal is properdin-dependent.

Matrix Considerations

Serum concentration, species source, complement integrity, endogenous regulators, anticoagulants, and sample storage conditions can all affect assay performance. Creative Biolabs can optimize matrix dilution, incubation time, temperature, buffer composition, and blocking conditions to reduce background and improve signal reliability.

Control Design

Controls are essential for properdin activity interpretation. Depending on the assay format, control sets may include heat-inactivated serum, properdin-depleted serum, reconstituted serum, pathway inhibitors, irrelevant antibody controls, known alternative pathway activators, no-serum controls, no-target controls, positive reference serum, and internal standard materials.

Why Choose Creative Biolabs?

Advantage	Description
Deep Complement Biology Expertise	Creative Biolabs has extensive experience in complement assay development, pathway-specific functional testing, complement component analysis, immune cell assays, antibody characterization, biologic evaluation, and therapeutic screening. This enables us to design assays that reflect both mechanistic complement biology and practical project goals.
Flexible Assay Customization	Complement properdin activity cannot be fully captured by a single universal assay. We customize assay format, matrix, species, target surface, readout, controls, and data analysis strategy according to the client's specific scientific question.
Multi-Readout Functional Assessment	We can combine upstream and downstream readouts, such as properdin binding, C3 convertase stabilization, C3b deposition, C5b-9 formation, and cell lysis, to provide a more complete picture of properdin activity.
Support for Therapeutic Development	Our properdin activity assays can support candidate screening, inhibitor potency testing, biologic characterization, mechanism-of-action analysis, and preclinical translational studies.
Integrated Complement Service Platform	Creative Biolabs offers a broad complement testing portfolio, allowing properdin activity testing to be integrated with C3, C5, Factor B, Factor D, Factor H, Factor I, CH50, AP50, C3b deposition, C5b-9 deposition, complement inhibition, and cell-based complement activity assays.
Client-Oriented Project Management	We work closely with clients from consultation through data delivery, providing clear communication, practical assay recommendations, and scientifically grounded interpretation.

Design Your Customization

Case Studies

Case 1

Enhanced Complement Activation by Structures of Properdin and Its Complex With the C-Terminal Domain of C3b

Properdin enhances complement-mediated opsonization of targeted cells and particles for immune clearance. Properdin occurs as dimers, trimers and tetramers in human plasma, which recognize C3b-deposited surfaces, promote formation, and prolong the lifetime of C3bBb-enzyme complexes that convert C3 into C3b, thereby enhancing the complement-amplification loop. The researchers reported crystal structures of monomerized properdin, which was produced by co-expression of separate N- and C-terminal constructs that yielded monomer-sized properdin complexes that stabilized C3bBb.

Monomerized Properdin binds and stabilizes C3 convertases. (OA Literature) Fig. 2 SPR analysis showing interaction of properdin with C3b and the C3b/C3 CTC domain.^1,2

References

Van den Bos, Ramon M., et al. "Insights into enhanced complement activation by structures of properdin and its complex with the C-terminal domain of C3b." Frontiers in immunology 10 (2019): 2097. https://doi.org/10.3389/fimmu.2019.02097
Distributed under Open Access license CC BY 4.0, without modification.

What Our Clients Say

"We needed a serum-compatible assay that could rank multiple antibody candidates against properdin while preserving alternative pathway biology. Creative Biolabs optimized a deposition-based readout with a robust signal window and provided dose-response analysis for our lead molecules. The assay design allowed us to compare potency, residual complement activity, and candidate behavior under biologically relevant matrix conditions. The data were easy to interpret and directly supported our lead selection discussion."

— Senior Scientist, Biologics Discovery Group

"Our project involved complement activation on engineered cells, and purified-protein assays did not fully reflect what we observed in serum. Creative Biolabs developed a cell-based assay to compare C3b, iC3b, and C5b-9 deposition under properdin-positive, properdin-depleted, and reconstituted conditions. This helped us understand whether alternative pathway amplification was contributing to complement activation on the cell surface."

— Translational Research Manager, Cell Therapy Company

"The final report included assay conditions, control design, raw data, normalized results, figures, and a clear interpretation of properdin-dependent activity. More importantly, the team suggested follow-up experiments to distinguish upstream properdin effects from downstream terminal pathway activation. Their recommendations helped us decide whether to expand the study into C3b deposition, C5b-9 deposition, and pathway-specific inhibition assays. This was very helpful for planning our next phase of preclinical work."

— Director of Preclinical Research, Immunology Program

"We were comparing human and animal serum activity for a preclinical complement study. Creative Biolabs helped us evaluate assay feasibility, select appropriate readouts, and interpret species-related differences in properdin-dependent alternative pathway activation. The project improved our confidence in selecting the right model system and helped us avoid overinterpreting results from a species with different complement behavior."

— Principal Investigator, Academic Immunology Laboratory

Frequently Asked Questions

When should I choose a Factor P activity assay instead of a properdin ELISA?

A properdin ELISA is useful when the main question is protein abundance. A Factor P activity assay is more appropriate when the question is functional, such as whether properdin supports alternative pathway amplification, whether a variant is functionally impaired, whether a candidate therapeutic blocks properdin function, or whether complement activation on a specific surface depends on properdin. In many projects, concentration and activity assays can be used together to distinguish low protein level from impaired protein function.

Can Creative Biolabs test properdin-depleted serum?

Yes. Properdin-depleted serum is a valuable matrix for confirming Factor P-dependent complement activity. Creative Biolabs can use depleted serum as a negative or mechanistic control and reconstitute it with purified or recombinant properdin to assess restoration of alternative pathway activity. This design is especially useful for demonstrating properdin dependency, testing recombinant properdin function, evaluating inhibitors, and interpreting suspected properdin deficiency.

Can Factor P variants or mutations be functionally analyzed?

Yes. Factor P variants can be evaluated using customized activity assays. Depending on the project, Creative Biolabs may compare wild-type and mutant properdin in a reconstituted system, measure restoration of alternative pathway activity, evaluate surface binding, monitor C3b deposition, or assess convertase stabilization. Functional analysis can help determine whether a variant affects properdin activity, even when protein expression or concentration data alone are inconclusive.

What cell types can be used in a cell-based Factor P activity assay?

Potential target cells may include endothelial cells, epithelial cells, tumor cells, immune cells, erythrocytes, engineered therapeutic cells, primary cells, immortalized cell lines, or disease-relevant cell models. The selection depends on the project goal, complement sensitivity of the cells, availability of detection reagents, and whether the assay is intended to measure deposition, lysis, inflammatory response, or another functional endpoint.

What samples are best for Factor P activity testing?

Serum is often preferred for complement functional assays because it preserves complement activity better than many other matrices. Properdin-depleted serum, reconstituted serum, purified properdin, recombinant properdin, biological fluids, cell culture supernatants, and therapeutic candidates can also be tested depending on assay format. The best sample type depends on whether the study is focused on endogenous activity, recombinant protein function, inhibitor activity, or complement activation on a target surface.